
- Pharmaceutical Executive-06-01-2008
- Volume 0
- Issue 0
John Shamsey, Bristol-Myers Squibb
S
John Shamsey
Senior director, managed markets strategy, Bristol-Myers Squibb
ACTIVE IN: Academy of Managed Care Pharmacy
USES: Longitudinal data to develop national account strategies
Medicare Part D had a significant impact on the industry, but John Shamsey, age 39, was ready for it. He had focused on managed markets early in his career, becoming versed in the intricacies of payers while his marketing colleagues considered the it an afterthought. As a result, Shamsey has become an unofficial spokesperson for Part D, explaining to colleagues in the company and the rest of the industry just how the whole thing works.
John Shamsey
"It gave me a chance to offer insight to others about what Medicare means to our current product portfolio, as well as for future products' value proposition development," says Shamsey. "The impact that managed markets and payers are having on our business will be really important for leaders to understand and to incorporate the perspective into the business."
Articles in this issue
over 17 years ago
Mary Szela, Abbottover 17 years ago
Mightier Than the Swordover 17 years ago
Keeshia Muhammad, Teva Specialty Pharmaceuticalsover 17 years ago
Eric Floyd, Cephalonover 17 years ago
Nancy Phelan, Wyethover 17 years ago
Tightening the Chainover 17 years ago
Kurt Graves, Vertexover 17 years ago
Wendy Niebler, Shireover 17 years ago
Perfectly ImperfectNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.